MST1 modulates Th17 activation in psoriasis via regulating TLR4-NF-κB pathway

Area of Science:

• Immunology
• Dermatology
• Molecular Biology

Background:

• Psoriasis is a chronic immune-mediated skin condition.
• The precise molecular mechanisms underlying psoriasis pathogenesis remain under investigation.
• The role of MST1 in T-cell activation and its involvement in psoriasis are not fully understood.

Purpose of the Study:

• To investigate the role of MST1 in psoriasis.
• To elucidate the mechanism by which MST1 influences T-helper 17 (Th17) cell activation and the NF-κB signaling pathway in psoriasis.

Main Methods:

• Analysis of skin samples and peripheral blood from psoriasis patients.
• In vitro culture of skin and T cells.
• Assessment of MST1, Th17 cells, and inflammatory cytokines (IL-17, IL-22, TNFα).
• Investigation of the TLR4-NF-κB signaling pathway.

Main Results:

• Elevated MST1 levels were observed in lesional skin and activated T cells of psoriasis patients.
• MST1 overexpression enhanced T-cell proliferation, migration, and production of IL-17, IL-22, and TNFα.
• MST1 knockdown reduced T-cell proliferation, migration, and cytokine production.
• MST1 was found to enhance TLR4-NF-κB signaling pathway activation.

Conclusions:

• MST1 plays a significant role in regulating Th17 cell activation in psoriasis.
• The MST1-mediated effects on Th17 activation are partly through the TLR4-NF-κB pathway.
• MST1 represents a potential therapeutic target for managing psoriasis.